Inhibition of DNA methylation by 5-Aza-2'-deoxycytidine suppresses the growth of human tumor cell lines

Cancer Research

Volumn 58, Issue 1, 1998, Pages 95-101

  Bender, Christina M ^a   Pao, Martha M ^a   Jones, Peter A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYTARABINE; DNA; PROTEIN P16;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL IMMORTALIZATION; CONTROLLED STUDY; DNA METHYLATION; DRUG CYTOTOXICITY; FIBROBLAST; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; SILENT GENE; TUMOR CELL LINE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA MODIFICATION METHYLASES; G1 PHASE; GENE EXPRESSION; HUMANS; MICE; MICE, NUDE; NEOPLASMS; RATS; RATS, NUDE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0031964055     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Jones, P. A. DNA methylation errors and cancer. Cancer Res., 56: 2463-2467, 1996.
2. Baylin, S. B., Makos, M., Wu, J.,Yen, R-W. C., deBustros, A., Vertino, P., and Nelkin, B. D. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells, 3: 383-390, 1991.
3. Jones, P. A., Wolkowicz, M. J., Rideout, W. M., III Gonzales, F. G., Marziasz, C. M., Coetzee, G. A., and Tapscott, S. J. De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc. Natl. Acad. Sci. USA, 87: 6117-6121, 1990.
4. Antequera, F., Boyes, J., and Bird, A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62: 503-514, 1990.
5. Bird, A. P. CpG-rich islands and the function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.
6. Gardiner-Garden, M., and Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol., 196: 261-282, 1987.
7. Li, E., Berad, C., and Jaenish, R. DNA methylation in genomic imprinting. Nature (Lond.), 386: 382-385, 1993.
8. Ferguson-Smith, A., Sasaki, C. H., Cattanach, B. M., and Surani, M. A. Parental origin specific epigenetic modification of the mouse H19 gene. Nature (Lond.), 382: 751-755, 1993.
9. Feinberg, A. P., and Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature (Lond.), 301: 89-92, 1983.
10. Jones, P. A., Rideout, W. M., Shen, J. C., Spruck, C. H., and Tsai, Y. C. Methylation, mutation, and cancer. Bioessays, 14: 33-38, 1992.
11. Rideout, W. M., Eversole-Cire, P., Spruck, C. H., Hastad, C. M., Coetzee, G. A., Gonzales, F. G., and Jones, P. A. Progressive increases in the methylation status and heterochromatinization of the Myo D1 CpG island during oncogenic transformation. Mol. Cell. Biol., 14: 6143-6152, 1994.
12. Baylin, S. B., Fearon, E. R., Vogelstein, B., de Bustros, A., Sarkis, S. J., Burke, P. J., Staal, S. P., and Nelkin, B. D. Hypermethylation of the 5′ region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood, 70: 412-417, 1987.
13. Vertino, P. M., Spillare, E. A., Harris, C. C., and Baylin, S. B. Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells. Cancer Res., 53: 1684-1689, 1993.
14. Greger, V., Passarge, E., Hopping, W., Messmer, E., and Horsethmke, B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet., 83: 155-158, 1989.
15. Sakai, T., Togushida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., and Dryja, T. P. Allele-specific hypermethylation of the retinoblastoma tumor suppressor gene. Am. Hum. Genet., 48: 880-888, 1991.
16. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D-S, Gnarra, J. R., Linehan, W. M., and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994.
17. Ottaviano, Y. L., Issa, J-P., Pari, F. F., Smith, H. S., Baylin, S. B., and Davidson, N. E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res., 54: 2552-2555, 1994.
18. Herman, J. G., Jen J., Merlo, A., and Baylin, S. B. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15/INK4B. Cancer Res., 56: 722-727, 1996.
19. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J-P., Davidson, N. E., Sidransky D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
20. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tomout, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4537, 1995.
21. Zhang, Y., Shields, T., Crenshaw, T., Hao, Y., Moulton, T., and Tycko, B. Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms' tumor and potential for somatic allele switching. Am. J. Hum. Genet., 53: 113-124, 1993.
22. Harris, M. Induction of thymidine kinase in enzyme deficient Chinese hamster cells. Cell, 29: 483-492, 1982.
23. Jones, P. A., and Taylor, S. M. Cellular differentiation, cytidine analogs, and DNA methylation. Cell, 20: 85-93, 1995.
24. Pinto, A., and Zagonel, V. 5-Aza-2′-deoxycytidine (Decitabine) and 5-Aza-cytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: past, present, and future trends. Leukemia (Baltimore), 1: 51-60, 1993.
25. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 386: 704-707, 1993.
26. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin dependent kinase 4-inhibitor gene in multiple human cancers. Nature (Lond.), 388: 753-756, 1994.
27. van der Reit, P., Nawroz, H., Hruban, R. H., Corio, R., Tokino, K., Koch, W., and Sidransky, D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res., 54: 1156-1158, 1994.
28. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995
29. Costello, J. F., Berger, M. S., Huang H-T., and Cavenee, W. K. Silencing of P16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res., 56: 2405-2410, 1996.
30. Lo, K. W., Cheung, S-T., van Hasselt, A., Tsang Y-S., Mak, K-F., Chung Y-F., Woo, K. K. S., Lee, J. C. K., and Huang, D. P. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res., 56: 2721-2725, 1996.
31. Otterson, G. A., Khlief, S. N., Chen, W., Coxon, A. B., and Kaye, F. J. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza-2′-deoxycytidine. Oncogene, 11: 1211-1216, 1995.
32. Gonzalgo, M. L., and Jones, P. A. Rapid quantitation of methylation at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res., 25: 2529-2531, 1997.
33. Clark, S. J., Harrison, J., Paul. C. L., and Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22: 2990-2997, 1994.
34. Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., and Paul, C. L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA, 89: 1827-1831, 1992.
35. Jones, P. A. Gene activation by 5-azacytidine. In: A. Razi, H. Cedar, and A. D. Riggs (eds.), DNA Methylation: Biochemistry and Biological Significance, pp. 165-187. New York: Springer-Verlag, 1984.
36. Hara, G., Smith, R., Parry, D., Tahara, H., Stone, S., and Peters, G. Regulation of p16/CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol., 16: 859-867, 1996.
37. Jones, P. A., Taylor, S. M., Mohandas, T., and Shapiro, L. J. Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Proc. Natl. Acad. Sci. USA. 79: 1215-1219, 1982.
38. Yoshiura, K., Kanai, Y., Ochiari, A., Shimoyama, Y., Sugimura, T., and Hirohashi, S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA, 92: 7416-7419, 1995.
39. INK4 gene by an adenovirus vector. Cancer Res., 55: 3250-3253, 1995.
40. Arap, A., Nishikawa, R., Furnari, F. B., Cavenee, W. K., and Su Huang, H-J. Replacement of the p16 gene suppresses human glioma cell growth. Cancer Res., 55: 1371-1374, 1995.